| Oct 21 |
FDA clamps partial hold on Phase III trial of BioNTech & OncoC4’s NSCLC therapy
|
| Oct 21 |
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
|
| Oct 18 |
mRNA licensing agreements surge 800% amid GSK lawsuits
|
| Oct 18 |
BioNTech and Moderna: A tale of two mRNA developers
|
| Oct 18 |
BioNTech shares slip as FDA places partial clinical hold on lung cancer study
|
| Oct 18 |
BioNTech, OncoC4 Phase 3 study put on partial hold by FDA
|
| Oct 16 |
GSK claims Moderna infringed mRNA vaccine patents
|
| Oct 15 |
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
|
| Oct 13 |
'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup
|
| Oct 8 |
Pfizer, BioNTech win lawsuit against CureVac over COVID vaccine patents in U.K.
|
